亚太药业：签署股份转让协议 控制权拟变更

Core Viewpoint - The announcement indicates a significant change in the ownership structure of Asia-Pacific Pharmaceutical, with the transfer of 14.61% of shares from the controlling shareholder, Fubon Group, to Xinghao Holdings and Xingchen Investment, potentially altering the company's management and control dynamics [1] Group 1: Share Transfer Details - Fubon Group and Hangu Investment plan to transfer 14.61% of the company's shares, totaling 109 million shares [1] - The transfer price is set at 8.26 yuan per share, amounting to a total of 900 million yuan [1] - If the transaction is completed, the controlling shareholder will shift from Fubon Group to Xinghao Holdings [1] Group 2: Management Control Changes - The actual controllers of the company will change from the management team led by Song Hanping, Fu Cai, and Hu Zhenghui to Qiu Zhongxun [1]